Short term biological effects of Zoledronate and Letrozole on invasive breast cancer (pre-operative study)

Trial Profile

Short term biological effects of Zoledronate and Letrozole on invasive breast cancer (pre-operative study)

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Letrozole; Zoledronic acid
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jan 2014 According to United Kingdom Clinical Research Network record, status changed from active, no longer recruiting to completed.
    • 24 Mar 2010 Results presented at the 7th European Breast Cancer Conference.
    • 08 Jan 2010 United Kingdom Clinical Research Network reports accrual to date changed from 82% to 74%.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top